Reflecting on PEGS Europe 2023
Drug Discovery World
NOVEMBER 30, 2023
In addition, the company presented three posters: ‘Integration of next-generation transposon vectors with state-of-art host cell lines’, ‘Application of gene editing technologies to improve biotherapeutic manufacturing’, and ‘CHOSOURCE ADCC+ cell line for enhanced therapeutic potency’.
Let's personalize your content